Delivery Order SPE2DE21D7020-SPE2D626F1958
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,118.95 by the Defense Health Agency's Medical Supply Chain on September 16, 2025. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of September 23, 2025 and carries no set-aside designation, indicating open competition in the federal marketplace. The work will be performed at Boston Scientific's...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $1,416.45 by the Defense Health Agency's Medical Supply Chain on July 29, 2025. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 5, 2025, and will be performed at Boston Scientific's facility in Marlborough, MA. The award uses no set-aside designation, allowing Boston Scientific to compete openly...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order with economic price adjustment valued at $4,860 by the Defense Health Agency's Medical Supply Chain division on September 2, 2025. The delivery order, with an ultimate completion date of September 9, 2025, represents a short-duration task order for specialized medical devices or equipment. As a major federal contractor, Boston Scientific supplies...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $13,027.08 by the Defense Health Agency's Medical Supply Chain on August 4, 2025. The contract, which utilizes fixed-price pricing with economic price adjustment, is scheduled for completion by August 11, 2025. The award represents a non-set-aside competitive procurement, and the place of performance is Boston Scientific's facility in Marlborough, MA. As...
- Boston Scientific Corp, a global medical technology company based in Marlborough, Massachusetts, has been awarded a $237,249.79 fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain on August 25, 2025. This delivery order, with an ultimate completion date of September 2, 2025, represents a component of Boston Scientific's broader federal contracting relationship with the Department of Defense healthcare system. The award carries no...
- Boston Scientific Corp, a Marlborough, Massachusetts-based global medical technology company, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on July 22, 2025, with an ultimate completion date of July 29, 2025. The contract, valued at $1,727.26, is structured as a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, indicating open competition in the federal marketplace. The award description references medical...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $11,312.43 by the Defense Health Agency's Medical Supply Chain program. The contract, awarded on August 14, 2025, with an ultimate completion date of August 21, 2025, utilizes fixed-price pricing with economic price adjustment. The delivery order is to be performed at Boston Scientific's facility in Marlborough, MA, and no small business set-aside...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,475.34 by the Defense Health Agency's Medical Supply Chain on September 12, 2025. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by September 19, 2025, and represents work to be performed at the company's facility in Marlborough, Massachusetts. The contract carries no set-aside designation,...
- Boston Scientific Corp, a major global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $32,850 by the Defense Health Agency's Medical Supply Chain under contract 4569047952. This fixed-price delivery order with economic price adjustment terms carries an ultimate completion date of August 18, 2025, and was issued on August 11, 2025. The contract is not set-aside and represents Boston Scientific's continued role as a prime...
- Boston Scientific Corp, a global medical device manufacturer headquartered in Marlborough, Massachusetts, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on September 29, 2025. This fixed-price contract with economic price adjustment carries a ceiling value of $3,362.95 and is scheduled for completion by October 6, 2025. The contract represents a single delivery order under Boston Scientific's established relationship with the Defense Health Agency and does not...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F1958Delivery Order
Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $1,727.26 by the Defense Health Agency's Medical Supply Chain on October 15, 2025. The contract, designated as a fixed-price agreement with economic price adjustment provisions, calls for delivery of specialized medical supplies with an ultimate completion date of October 22, 2025. The award was made without set-aside restrictions, allowing Boston Scientific to compete openly in the federal marketplace. Performance of this delivery order will occur at the company's facility in Marlborough, MA. This delivery order represents a continuation of Boston Scientific's substantial federal contracting relationship with the Defense Health Agency, which has consistently awarded the company contracts for advanced medical devices and solutions. Boston Scientific maintains multiple indefinite delivery vehicles with federal healthcare agencies, including a significant blanket purchase agreement with the Defense Health Agency for radiation treatment devices valued at $750,000 through March 2030. The company's federal portfolio encompasses critical medical technologies such as cardiac devices, stents, catheters, and diagnostic equipment supplied to agencies including the Department of Veterans Affairs and the Defense Logistics Agency, positioning the company as a key supplier within the federal healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/15/25 |